JP2010500973A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500973A5
JP2010500973A5 JP2009521781A JP2009521781A JP2010500973A5 JP 2010500973 A5 JP2010500973 A5 JP 2010500973A5 JP 2009521781 A JP2009521781 A JP 2009521781A JP 2009521781 A JP2009521781 A JP 2009521781A JP 2010500973 A5 JP2010500973 A5 JP 2010500973A5
Authority
JP
Japan
Prior art keywords
composition
composition according
compound
epicatechin
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/016504 external-priority patent/WO2008011173A2/en
Publication of JP2010500973A publication Critical patent/JP2010500973A/ja
Publication of JP2010500973A5 publication Critical patent/JP2010500973A5/ja
Pending legal-status Critical Current

Links

JP2009521781A 2006-07-21 2007-07-20 アルギナーゼ濃度／活性の改善 Pending JP2010500973A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83268406P 2006-07-21 2006-07-21
PCT/US2007/016504 WO2008011173A2 (en) 2006-07-21 2007-07-20 Improvement of arginase levels/activity

Publications (2)

Publication Number Publication Date
JP2010500973A JP2010500973A (ja) 2010-01-14
JP2010500973A5 true JP2010500973A5 (enExample) 2010-09-09

Family

ID=38957417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521781A Pending JP2010500973A (ja) 2006-07-21 2007-07-20 アルギナーゼ濃度／活性の改善

Country Status (9)

Country Link
US (3) US20080021097A1 (enExample)
EP (2) EP2438915A1 (enExample)
JP (1) JP2010500973A (enExample)
CN (1) CN101516407B (enExample)
AU (1) AU2007275561B2 (enExample)
CA (1) CA2657915A1 (enExample)
IL (1) IL196480A0 (enExample)
RU (2) RU2469742C2 (enExample)
WO (1) WO2008011173A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2418949A4 (en) * 2009-04-17 2012-11-28 Cardero Therapeutics Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF ISCHEMIC ILLNESSES AND SUFFERING IN CONNECTION WITH THE MITOCHONDRY FUNCTION
FR2973234A1 (fr) * 2011-03-31 2012-10-05 Oreal Utilisation cosmetique d'inhibiteur d'arginase, comme agent pour freiner la chute des cheveux, des sourcils et/ou des cils
JP2014521702A (ja) * 2011-08-05 2014-08-28 カーデロ セラピューティクス インコーポレイテッド フラボノイド化合物
US9266260B2 (en) * 2011-12-20 2016-02-23 Massachusetts Institute Of Technology Precision continuous stamp casting method for roll-based soft lithography
AU2013301215B2 (en) * 2012-08-07 2016-06-30 Indus Biotech Private Limited A method of managing diabetic foot ulcers, pressure ulcers, venous leg ulcers and associated complication
US11229685B2 (en) 2013-01-29 2022-01-25 Case Western Reserve University Fungal iron acquisition inhibitors and uses thereof
WO2016046375A1 (en) * 2014-09-25 2016-03-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Theobroma cacao extract for use in the treatment or prevention of receptor tyrosine kinases related disorders
US20160199463A1 (en) * 2014-12-15 2016-07-14 The Johns Hopkins University Hdac2 defends vascular endothelium from injury
WO2017086421A1 (ja) * 2015-11-18 2017-05-26 東京応化工業株式会社 アルギナーゼ活性の測定方法、アルギナーゼ活性の検出キット、アルギナーゼ関連疾患検出キット、及びアルギナーゼの阻害剤又は活性剤のスクリーニング方法
WO2017085947A1 (ja) * 2015-11-18 2017-05-26 東京応化工業株式会社 アルギナーゼ活性の測定方法、アルギナーゼ活性の検出キット及びアルギナーゼ関連疾患検出キット
EP3379248B1 (en) * 2015-11-18 2020-09-23 Tokyo Ohka Kogyo Co., Ltd. Arginase activity measurement method, arginase activity detection kit, arginase-related disease detection kit, and arginase inhibitor or active agent screening method
JP6925163B2 (ja) * 2017-05-16 2021-08-25 東京応化工業株式会社 尿素の測定方法及び尿素検出キット
CN107815370A (zh) * 2017-11-17 2018-03-20 华坪县腾辉酒业有限公司 一种蓝莓露酒及其制备方法
US11269896B2 (en) 2019-09-10 2022-03-08 Fujitsu Limited System and method for automatic difficulty level estimation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
US6469053B1 (en) * 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US6297273B1 (en) 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US6312753B1 (en) 1996-09-06 2001-11-06 Mars, Incorporated Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
US6015913A (en) 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans
US6207842B1 (en) 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
EP1049660A1 (en) * 1997-10-10 2000-11-08 The Trustees Of The University Of Pennsylvania Compositions and methods for inhibiting arginase activity
ATE372972T1 (de) * 1998-03-12 2007-09-15 Mars Inc Produkte enthaltend polyphenol(e) und l-arginin zur stimulierung der stickstoffoxidproduktion
US6805883B2 (en) * 1998-03-12 2004-10-19 Mars, Incorporated Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US6156912A (en) 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
JP2001013453A (ja) * 1999-06-28 2001-01-19 Canon Inc 光学装置
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
JP4112764B2 (ja) * 1999-11-19 2008-07-02 株式会社伊勢半 皮膚外用剤
US6627232B1 (en) 2000-06-09 2003-09-30 Mars Incorporated Method for extracting cocoa procyanidins
WO2003032969A2 (en) * 2001-10-15 2003-04-24 National Research Council Of Canada Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
US7514107B2 (en) * 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
US20040115285A1 (en) * 2002-12-13 2004-06-17 Peter Rohdewald Method of normalizing glucose levels in blood of patients with diabetes mellitus by oral administration of proanthocyanidins containing plant extracts
US20050277600A1 (en) * 2004-06-14 2005-12-15 Mars, Incroporated Compositions and methods of use of dimer digallates
US20090047368A1 (en) * 2004-11-04 2009-02-19 University Of Tsukuba Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage
US20060293258A1 (en) * 2005-06-23 2006-12-28 Peter Rohdewald Method and composition to treat skin ulcers
US20060293259A1 (en) * 2005-06-28 2006-12-28 Mars, Incorporated Compositions and methods of use of derivatized flavanols
WO2007002851A2 (en) * 2005-06-29 2007-01-04 Mars, Incorporated Thermally-processed cocoa products useful for vascular health improvement
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521

Similar Documents

Publication Publication Date Title
JP2010500973A5 (enExample)
US20240366589A1 (en) Nhe3-binding compounds and methods for inhibiting phosphate transport
RU2009106041A (ru) Снижение уровней/активности аргиназы
US20210069222A1 (en) Treatment of metabolic disorders in equine animals
EP3125882B1 (en) Treatment of metabolic disorders in equine animals
CN102105153B (zh) Sglt2抑制剂的医药用途和含该抑制剂的组合物
CN104906582A (zh) 包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
HK1201721A1 (en) Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative
US20130310454A1 (en) Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
JP2014500246A5 (enExample)
US20200315998A1 (en) Composition for improving intestinal barrier function
CN105801663A (zh) 一种熊果酸小檗碱偶合物的制备方法及医药用途
RU2786149C2 (ru) Nhe3-связывающие соединения и способы ингибирования транспорта фосфатов
HK40016193A (en) Nhe3-binding compounds for inhibiting phosphate transport
HK40073916A (en) Nhe3-binding compounds and methods for inhibiting phosphate transport
CN102648919A (zh) 葡甘聚糖的新用途
HK1221400B (en) Nhe3-binding compounds and methods for inhibiting phosphate transport
Gumprecht Cardiovascular safety of SGLT2 inhibitors
HK1143951A (en) Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative